BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7584111)

  • 1. A new reporter system for detection of retroviral infection.
    Planelles V; Haislip A; Withers-Ward ES; Stewart SA; Xie Y; Shah NP; Chen IS
    Gene Ther; 1995 Aug; 2(6):369-76. PubMed ID: 7584111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered replication of human immunodeficiency virus type 1 (HIV-1) in T cell lines retrovirally transduced to express Herpesvirus saimiri proteins StpC and/or Tip.
    Henderson EE; Tsygankov AY; Merlo JJ; Romano G; Guan M
    Virology; 1999 Nov; 264(1):125-33. PubMed ID: 10544137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients.
    Stitz J; Steidl S; Merget-Millitzer H; König R; Müller P; Nocken F; Engelstädter M; Bobkova M; Schmitt I; Kurth R; Buchholz CJ; Cichutek K
    Virology; 2000 Feb; 267(2):229-36. PubMed ID: 10662618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.
    Ahmad A; Ladha A; Cohen EA; Menezes J
    Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
    Peng H; Callison D; Li P; Burrell C
    Virology; 1996 Jun; 220(2):377-89. PubMed ID: 8661389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV-1 in CEM cells by a potent TAR decoy.
    Lee SW; Gallardo HF; Gaspar O; Smith C; Gilboa E
    Gene Ther; 1995 Aug; 2(6):377-84. PubMed ID: 7584112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitat gene therapy: a candidate for late-stage AIDS patients.
    Lisziewicz J; Sun D; Lisziewicz A; Gallo RC
    Gene Ther; 1995 May; 2(3):218-22. PubMed ID: 7614253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
    Junker U; Böhnlein E; Veres G
    Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo transduction and expansion of CD4+ lymphocytes from HIV + donors: prelude to a ribozyme gene therapy trial.
    Leavitt MC; Yu M; Wong-Staal F; Looney DJ
    Gene Ther; 1996 Jul; 3(7):599-606. PubMed ID: 8818647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HIV-1 replication in chronically infected cell lines and peripheral blood mononuclear cells by retrovirus-mediated antitat gene transfer.
    Li Y; Starr SE; Lisziewicz J; Ho WZ
    Gene Ther; 2000 Feb; 7(4):321-8. PubMed ID: 10694813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrovirus mediated in vivo gene transfer to synovium in bacterial cell wall-induced arthritis in rats.
    Makarov SS; Olsen JC; Johnston WN; Schwab JH; Anderle SK; Brown RR; Haskill JS
    Gene Ther; 1995 Aug; 2(6):424-8. PubMed ID: 7584118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus facilitated infection of human cells with ecotropic retrovirus.
    Scott-Taylor TH; Gallardo HF; Gänsbacher B; Sadelain M
    Gene Ther; 1998 May; 5(5):621-9. PubMed ID: 9797866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.
    Plavec I; Agarwal M; Ho KE; Pineda M; Auten J; Baker J; Matsuzaki H; Escaich S; Bonyhadi M; Böhnlein E
    Gene Ther; 1997 Feb; 4(2):128-39. PubMed ID: 9081703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
    Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
    Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of HIV-1 replication by retroviral vectors expressing monomeric and multimeric hammerhead ribozymes.
    Ramezani A; Ding SF; Joshi S
    Gene Ther; 1997 Aug; 4(8):861-7. PubMed ID: 9338016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.
    Schnierle BS; Moritz D; Jeschke M; Groner B
    Gene Ther; 1996 Apr; 3(4):334-42. PubMed ID: 8732165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retroviral vector capable of targeted gene transfer into cells expressing HIV envelope glycoprotein.
    Suzuki S; Shimada T
    Biochem Biophys Res Commun; 2000 May; 271(3):672-6. PubMed ID: 10814520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficiency virus retroviral vector.
    Shimada T; Fujii H; Mitsuya H; Nienhuis AW
    J Clin Invest; 1991 Sep; 88(3):1043-7. PubMed ID: 1885765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
    Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
    J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient transduction and selection of human T-lymphocytes with bicistronic Thy1/HSV1-TK retroviral vector produced by a human packaging cell line.
    Lemoine FM; Mesel-Lemoine M; Cherai M; Gallot G; Vié H; Leclercq V; Trébèden-Negre H; Mammès O; Boyer O; Noguiez-Hellin P; Klatzmann D
    J Gene Med; 2004 Apr; 6(4):374-86. PubMed ID: 15079812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.